Moraga P, Collaborators GCoD. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151–210.
World Health Organization (WHO). Global Health Estimates 2016: Disease burden by cause, age, sex, by country and by region, 2000–2016. Geneva, Switzerland: WHO; 2018.
Hare CB. HIV InSite Knowledge Base Chapter-January. In: Clinical overview of HIV disease; 2006.
Haynes BF, Pantaleo G, Fauci AS. Toward an understanding of the correlates of protective immunity to HIV infection. Science. 1996;271(5247):324–8.
Maartens G, Celum C, Lewin SR. HIV infection: epidemiology, pathogenesis, treatment, and prevention. Lancet. 2014;384(9939):258–71.
Case KK, Ghys PD, Gouws E, Eaton JW, Borquez A, Stover J, Cuchi P, Abu-Raddad LJ, Garnett GP, Hallett TB. Understanding the modes of transmission model of new HIV infection and its use in prevention planning. Bull World Health Organ. 2012;90:831–838A.
Herbeck JT, Mittler JE, Gottlieb GS, Mullins JI. An HIV epidemic model based on viral load dynamics: value in assessing empirical trends in HIV virulence and community viral load. PLoS Comput Biol. 2014;10(6):e1003673.
Lecher S. Progress with scale-up of HIV viral load monitoring—seven sub-Saharan African countries, January 2015–June 2016. MMWR Morb Mortal Wkly Rep. 2016;65:1332–5.
Sabin CA, Mocroft A, Cozzi Lepri A, Phillips AN. Cofactors and markers of disease progression in human immunodeficiency virus infection. J R Stat Soc. 1998;161(2):177–89.
Organization WH. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach-2010 revision. 2010.
Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373(9657):48–57.
Mangal TD. Joint estimation of CD4+ cell progression and survival in untreated individuals with HIV-1 infection. AIDS (London, England). 2017;31(8):1073.
Binquet C, Le Teuff G, Abrahamovicz M, Mahboubi A, Yazdanpanah Y, Rey D, Rabaud C, Chirouze C, Berger J, Faller J. Markov modelling of HIV infection evolution in the HAART era. Epidemiol Infect. 2009;137(9):1272–82.
RdVCd O, Shimakura SE, Campos DP, Victoriano FP, Ribeiro SR, Veloso VG, Grinsztejn B, Carvalho MS. Multi-state models for defining degrees of chronicity related to HIV-infected patient therapy adherence. Cad Saude Publica. 2013;29:801–11.
Gillis J, Loutfy M, Bayoumi AM, Antoniou T, Burchell AN, Walmsley S, Cooper C, Klein MB, Machouf N, Montaner JS. A multi-state model examining patterns of transitioning among states of engagement in care in HIV-positive individuals initiating combination antiretroviral therapy. J Acquir Immune Defic Syndr (1999). 2016;73(5):531.
Shoko C, Chikobvu D. Time-homogeneous Markov process for HIV/AIDS progression under a combination treatment therapy: cohort study, South Africa. Theor Biol Med Model. 2018;15(1):3.
Chikobvu D, Shoko C. A Markov model to estimate mortality due to HIV/AIDS using CD4 cell counts based states and viral load: a principal component analysis approach. Biomed Res. 2018;29(15):3090–8.
Abner EL, Nelson PT, Schmitt FA, Browning SR, Fardo DW, Wan L, Jicha GA, Cooper GE, Smith CD, Caban-Holt AM. Self-reported head injury and risk of late-life impairment and AD pathology in an AD center cohort. Dement Geriatr Cogn Disord. 2014;37(5–6):294–306.
Organization WH. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. 2007.
van Loggerenberg F, Mlisana K, Williamson C, Auld SC, Morris L, Gray CM, Karim QA, Grobler A, Barnabas N, Iriogbe I. Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study. PLoS One. 2008;3(4):e1954.
Garrett N, Norman E, Leask K, Naicker N, Asari V, Majola N, Karim QA, Karim SSA. Acceptability of early antiretroviral therapy among South African women. AIDS Behav. 2018;22(3):1018–24.
Karim QA, Karim SSA, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany AB, Sibeko S, Mlisana KP, Omar Z. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168–74.
Mlisana K, Werner L, Garrett NJ, McKinnon LR, van Loggerenberg F, Passmore J-AS, Gray CM, Morris L, Williamson C, Abdool Karim SS. Rapid Disease Progression in HIV-1 Subtype C–Infected South African Women. Clin Infect Dis. 2014;59(9):1322–31.
WHOQoL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28(3):551–8.
Hamidi O, Tapak L, Poorolajal J, Amini P. Identifying risk factors for progression to AIDS and mortality post-HIV infection using illness-death multistate model. Clin Epidemiol Glob Health. 2017;5(4):163–8.
Beyersmann J, Latouche A, Buchholz A, Schumacher M. Simulating competing risks data in survival analysis. Stat Med. 2009;28(6):956–71.
Ieva F, Jackson CH, Sharples LD. Multi-State modelling of repeated hospitalisation and death in patients with Heart Failure: the use of large administrative databases in clinical epidemiology. Stat Methods Med Res. 2017;26(3):1350–72.
Titman AC, Sharples LD. Model diagnostics for multi-state models. Stat Methods Med Res. 2010;19(6):621–51.
Shoko C, Chikobvu D, Bessong PO. A Markov Model to Estimate Mortality Due to HIV/AIDS Using Viral Load Levels-Based States and CD4 Cell Counts: A Principal Component Analysis Approach. Infect Dis Ther. 2018;7(4):457–71.
Kwantwi LB, Tunu BK, Boateng D, Quansah DY. Body mass index, haemoglobin, and total lymphocyte count as a surrogate for CD4 count in resource limited settings. J biomark. 2017;2017:7907352.
Obirikorang C, Quaye L, Acheampong I. Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings. BMC Infect Dis. 2012;12(1):128.
Tinarwo P, Zewotir T, Yende-Zuma N, Garrett NJ, North D. An Evaluation to Determine the Strongest CD4 Count Covariates during HIV Disease Progression in Women in South Africa. Infect Dis Ther. 2019;8(2):269–84.
De Santis GC, Brunetta DM, Vilar FC, Brandao RA, de Albernaz Muniz RZ, de Lima GMN, Amorelli-Chacel ME, Covas DT, Machado AA. Hematological abnormalities in HIV-infected patients. Int J Infect Dis. 2011;15(12):e808–11.
Obirikorang C, Yeboah FA. Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting. J Biomed Sci. 2009;16(1):102.
Vanisri H, Vadiraja N. Relationship between Red blood cell parameters and immune status in HIV infected females. Indian J Pathol Oncol. 2016;3(2):255–9.
Nagu T, Kanyangarara M, Hawkins C, Hertmark E, Chalamila G, Spiegelman D, Mugusi F, Fawzi W. Elevated alanine aminotransferase in antiretroviral-naïve HIV-infected African patients: magnitude and risk factors. HIV Med. 2012;13(9):541–8.
Quaye O, Kuleape JA, Bonney EY, Puplampu P, Tagoe EA. Imbalance of antioxidant enzymes activities and trace elements levels in Ghanaian HIV-infected patients. PLoS One. 2019;14(7):e0220181.
Shiferaw MB, Tulu KT, Zegeye AM, Wubante AA. Liver enzymes abnormalities among highly active antiretroviral therapy experienced and HAART naïve HIV-1 infected patients at Debre Tabor Hospital, North West Ethiopia: a comparative cross-sectional study. AIDS Res Treat. 2016;2016:1985452.
Moore RD, Forney D. Anemia in HIV-infected patients receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr (1999). 2002;29(1):54–7.
Calles, NR, Evans, D, Terlonge, D. Pathophysiology of the human immunodeficiency virus. In: HIV Curriculum for the Health Professional. Houston, TX: Baylor International Pediatric AIDS Initiative, Baylor College of Medicine; 2006:11–22.
Deressa T, Damtie D, Workineh M, Genetu M, Melku M. Anemia and thrombocytopenia in the cohort of HIV-infected adults in Northwest Ethiopia: a facility-based cross-sectional study. EJIFCC. 2018;29(1):36.
Volberding PA, Levine AM, Dieterich D, Mildvan D, Mitsuyasu R, Saag M, Group AiHW. Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin Infect Dis. 2004;38(10):1454–63.
Parinitha S, Kulkarni M. Haematological changes in HIV infection with correlation to CD4 cell count. Australas Med J. 2012;5(3):157.
Ferede G, Wondimeneh Y. Prevalence and related factors of anemia in HAART-naive HIV positive patients at Gondar University Hospital, Northwest Ethiopia. BMC Blood Disord. 2013;13(1):8.
Pawlowski A, Jansson M, Sköld M, Rottenberg ME, Källenius G. Tuberculosis and HIV co-infection. PLoS Pathog. 2012;8(2):e1002464.
Siika AM, Yiannoutsos CT, Wools-Kaloustian KK, Musick BS, Mwangi AW, Diero LO, Kimaiyo SN, Tierney WM, Carter JE. Active tuberculosis is associated with worse clinical outcomes in HIV-infected African patients on antiretroviral therapy. PLoS One. 2013;8(1):e53022.
Skogmar S, Schön T, Balcha TT, Jemal ZH, Tibesso G, Björk J, Björkman P. CD4 cell levels during treatment for tuberculosis (TB) in Ethiopian adults and clinical markers associated with CD4 lymphocytopenia. PLoS One. 2013;8(12):e83270.
Cingolani A, Cozzi Lepri A, Castagna A, Goletti D, De Luca A, Scarpellini P, Fanti I, Antinori A, d'Arminio Monforte A, Girardi E. Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition. Clin Infect Dis. 2011;54(6):853–61.
World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. 2nd ed. Geneva, Switzerland: WHO; 2016.
Vu T, Boggiano V, Tran B, Nguyen L, Tran T, Latkin C, Ho C, Ho R. Sexual risk behaviors of patients with HIV/AIDS over the course of antiretroviral treatment in Northern Vietnam. Int J Environ Res Public Health. 2018;15(6):1106.
Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, Moore J, Group HERS. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001;285(11):1466–74.
Rivera-Rivera Y, Vazquez-Santiago FJ, Albino E, Sanchez MD, Rivera-Amill V. Impact of depression and inflammation on the progression of HIV disease. J Clin Cell Immunol. 2016;7(3):423.
Seyoum A, Temesgen Z. Joint longitudinal data analysis in detecting determinants of CD4 cell count change and adherence to highly active antiretroviral therapy at Felege Hiwot Teaching and Specialized Hospital, North-west Ethiopia (Amhara Region). AIDS Res Ther. 2017;14(1):14.
Jiang H, Xie N, Cao B, Tan L, Fan Y, Zhang F, Yao Z, Liu L, Nie S. Determinants of progression to AIDS and death following HIV diagnosis: a retrospective cohort study in Wuhan, China. PLoS One. 2013;8(12):e83078.
Yallew WW, Terefe MW, Herchline TE, Sharma HR, Bitew BD, Kifle MW, Tetemke DM, Tefera MA, Adane MM. Assessment of water, sanitation, and hygiene practice and associated factors among people living with HIV/AIDS home based care services in Gondar city, Ethiopia. BMC Public Health. 2012;12(1):1057.
Yates T, Lantagne D, Mintz E, Quick R. The impact of water, sanitation, and hygiene interventions on the health and well-being of people living with HIV: a systematic review. J Acquir Immune Defic Syndr. 2015;68:S318–30.
Crum-Cianflone NF, Roediger M, Eberly LE, Ganesan A, Weintrob A, Johnson E, Agan BK, Group IDCRPHW. Impact of weight on immune cell counts among HIV-infected persons. Clin Vaccine Immunol. 2011;18(6):940–6.
Shuter J, Chang CJ, Klein RS. Prevalence and predictive value of overweight in an urban HIV care clinic. J Acquir Immune Defic Syndr (1999). 2001;26(3):291–7.
Li X, Ding H, Geng W, Liu J, Jiang Y, Xu J, Zhang Z, Shang H. Predictive effects of body mass index on immune reconstitution among HIV-infected HAART users in China. BMC Infect Dis. 2019;19(1):373.
Womack J, Tien PC, Feldman J, Shin JH, Fennie K, Anastos K, Cohen MH, Bacon MC, Minkoff H. Obesity and immune cell counts in women. Metabolism. 2007;56(7):998–1004.
Weinfurt KP, Willke RJ, Glick HA, Freimuth WW, Schulman KA. Relationship between CD4 count, viral burden, and quality of life over time in HIV-1-infected patients. Med Care. 2000;38(4):404–10.
Venter E, Gerike G, Bekker P. Nutritional status, quality of life and CD4 cell count of adults living with HIV/AIDS in the Ga-Rankuwa area (South Africa). S Afr J Clin Nutr. 2009;22(3):124–9.
Call S, Klapow J, Stewart K, Westfall A, Mallinger A, DeMasi R, Centor R, Saag M. Health-related quality of life and virologic outcomes in an HIV clinic. Qual Life Res. 2000;9(9):977–85.
Ingumbor J, Steward A, Holzemer W. Comparison of the health related quality of life, CD4 count and viral load of AIDS patients with HIV who have been on treatment for 12 months in rural South Africa; 2013.
Mwesigire DM, Martin F, Seeley J, Katamba A. Relationship between CD4 count and quality of life over time among HIV patients in Uganda: a cohort study. Health Qual Life Outcomes. 2015;13(1):1.